Cancer is a therapeutic area in which there is a considerable need for new and better treatments. In the US, Western Europe and Japan, an estimated 3 million people each year are diagnosed with cancer. Cancer is characterised by abnormal cell growth resulting in the development of a mass of cells commonly known as a tumour.
Cancer can arise in almost any tissue or organ within the human body.
Natural chemicals and many other current methods of cancer chemotherapy treat the disease by killing cancer cells directly. However, the use of such drugs may be limited by their adverse side effects and the existence of resistance mechanisms in tumour cells. Xenova is focusing on targets in these areas, with the aim of producing drug candidates with the potential for improved efficacy and reduced side effects relative to currently available therapies. For more information on Xenova's individual cancer programmes, please select 'Drug Candidates' on the navigation bar.